Literature DB >> 31788387

Light-intensity Activity-related Nausea: An Unusual Presentation of Pheochromocytoma.

Sakditad Saowapa1, Parin Rattananon1, Chutintorn Sriphrapradang1.   

Abstract

Pheochromocytomas are rare neuroendocrine tumors arising from chromaffin cells of the adrenal gland. Because of their highly variable clinical spectrum, these tumors often go undiagnosed and result in life-threatening complications. The typical presentations include episodic headache, palpitations and sweating accompanied with sustained or paroxysmal hypertension. However, less than half of pheochromocytoma patients have these classic symptoms. Many patients present with atypical symptoms, which could be overlooked. Our case represents an unusual presentation of pheochromocytoma, which is not well recognized as a possible manifestation. A 60-year-old woman presented with light-intensity-related nausea, which progressed to severe vomiting with hypovolemic shock. An unexpected adrenal mass was found during sonographic evaluation of the volume status. Pheochromocytoma was confirmed by 24-hour urine fractionated metanephrines and a computed tomography (CT) scan. In pheochromocytomas, the elevation of circulating catecholamines activates alpha-adrenergic receptors in the area postrema, which then initiates the emetic cascade. Light-intensity activity-related nausea and vomiting, especially when present with other symptoms of catecholamine excess, could be considered as a clinical presentation of pheochromocytomas.
Copyright © 2019, Saowapa et al.

Entities:  

Keywords:  adrenal gland neoplasm; area postrema; catecholamines; metabolic equivalent; vomiting

Year:  2019        PMID: 31788387      PMCID: PMC6857826          DOI: 10.7759/cureus.5930

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Alpha adrenoceptor subtypes involved in the emetic action in dogs.

Authors:  Y Hikasa; S Ogasawara; K Takase
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

Review 2.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  2011 Compendium of Physical Activities: a second update of codes and MET values.

Authors:  Barbara E Ainsworth; William L Haskell; Stephen D Herrmann; Nathanael Meckes; David R Bassett; Catrine Tudor-Locke; Jennifer L Greer; Jesse Vezina; Melicia C Whitt-Glover; Arthur S Leon
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

4.  Central mechanisms of vomiting related to catecholamine response: anaesthetic implication.

Authors:  L C Jenkins; D Lahay
Journal:  Can Anaesth Soc J       Date:  1971-07

5.  Circulating catecholamines and some cardiovascular, respiratory, metabolic and pupillary responses during diethyl ether anaesthesia.

Authors:  G W Black; L McArdle; H McCullough; V K Unni
Journal:  Anaesthesia       Date:  1969-04       Impact factor: 6.955

Review 6.  Central neurocircuitry associated with emesis.

Authors:  P J Hornby
Journal:  Am J Med       Date:  2001-12-03       Impact factor: 4.965

7.  The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.

Authors:  D Jovanović-Mićić; R Samardzić; D B Beleslin
Journal:  Eur J Pharmacol       Date:  1995-01-05       Impact factor: 4.432

Review 8.  Anaesthesia and emesis. I: Etiology.

Authors:  M G Palazzo; L Strunin
Journal:  Can Anaesth Soc J       Date:  1984-03

9.  Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma.

Authors:  Kathryn S King; Nissar A Darmani; Marybeth S Hughes; Karen T Adams; Karel Pacak
Journal:  Endocrine       Date:  2010-04-21       Impact factor: 3.633

Review 10.  European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

Authors:  P F Plouin; L Amar; O M Dekkers; M Fassnacht; A P Gimenez-Roqueplo; J W M Lenders; C Lussey-Lepoutre; O Steichen
Journal:  Eur J Endocrinol       Date:  2016-05       Impact factor: 6.664

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.